dipyridamole has been researched along with Necrobiosis Lipoidica in 9 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Necrobiosis Lipoidica: A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen patients with a clinical and histological diagnosis of necrobiosis lipoidica were treated in a double-blind control study with either an aspirin dipyridamole combination or a matching placebo for an 8-week period." | 9.05 | A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica. ( Finlay, AY; Marks, R; Statham, B, 1981) |
| "Fourteen patients with a clinical and histological diagnosis of necrobiosis lipoidica were treated in a double-blind control study with either an aspirin dipyridamole combination or a matching placebo for an 8-week period." | 5.05 | A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica. ( Finlay, AY; Marks, R; Statham, B, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiquan, S | 1 |
| Khalaf, AT | 1 |
| Jinquan, T | 1 |
| Xiaoming, L | 1 |
| Statham, B | 1 |
| Finlay, AY | 2 |
| Marks, R | 2 |
| Kakinuma, H | 1 |
| Fuzisawa, S | 1 |
| Usami, Y | 1 |
| Statham, BN | 1 |
| Eldor, A | 1 |
| Diaz, EG | 1 |
| Naparstek, E | 1 |
| Császár, A | 1 |
| Daróczy, J | 1 |
| Szénási, P | 1 |
| Anda, L | 1 |
| Tóth, L | 1 |
| Hosszúfalusi, N | 1 |
| Karádi, I | 1 |
| Kalabay, L | 1 |
| Romics, L | 1 |
| Quimby, SR | 1 |
| Muller, SA | 1 |
| Schroeter, AL | 1 |
| Fuster, V | 1 |
| Kazmier, FJ | 1 |
| Heng, MC | 1 |
| Song, MK | 1 |
| Heng, MK | 1 |
1 review available for dipyridamole and Necrobiosis Lipoidica
| Article | Year |
|---|---|
[Necrobiosis lipoidica without diabetes mellitus (diagnostic and therapeutic possibilities)].
Topics: Aspirin; Basement Membrane; Capillaries; Diabetic Angiopathies; Diagnosis, Differential; Dipyridamol | 1989 |
2 trials available for dipyridamole and Necrobiosis Lipoidica
| Article | Year |
|---|---|
A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
Topics: Adolescent; Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combin | 1981 |
Aspirin and dipyridamole ineffective in treatment of necrobiosis lipoidica.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Hum | 1980 |
6 other studies available for dipyridamole and Necrobiosis Lipoidica
| Article | Year |
|---|---|
Necrobiosis lipoidica: a case with histopathological findings revealed asteroid bodies and was successfully treated with dipyridamole plus intralesional triamcinolone.
Topics: Dipyridamole; Drug Therapy, Combination; Female; Giant Cells; Humans; Immunosuppressive Agents; Midd | 2008 |
[A case of necrobiosis lipoidica diabeticorum (author's transl)].
Topics: Adult; Aspirin; Dipyridamole; Humans; Male; Necrobiosis Lipoidica | 1981 |
Treatment of diabetic necrobiosis with aspirin and dipyridamole.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Female; Humans; Necrobiosis Lipoidica | 1978 |
Treatment of diabetic necrobiosis with aspirin or dipyridamole.
Topics: Adolescent; Adult; Animals; Aspirin; Diabetes Complications; Diabetes Mellitus, Type 1; Dipyridamole | 1978 |
Necrobiosis lipoidica diabeticorum: platelet survival and response to platelet inhibitors.
Topics: Adult; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Drug Administration Schedule; Drug The | 1989 |
Healing of necrobiotic ulcers with antiplatelet therapy. Correlation with plasma thromboxane levels.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Humans; Leg Ulcer; M | 1989 |